4:59 NewCo, a 5AM Ventures Company Information
Contact top employees from
4:59 NewCo, a 5AM Ventures Company
Summary
4:59 is a hands-on internal effort of 5AM Ventures to discover, incubate, and fund breakthrough science. We seek to partner alongside academics and entrepreneurs --often serving as an extension of the...Show more
Industries
Biotechnology
Headquarters Location
Employees Size
10-50 employees
Employees Turnover 2 quarter 2025
Number of employees switched from or switched to
Total number all of employee turnover
Length of Employment
Employee tenure at 4:59 NewCo, a 5AM Ventures Company shows a diverse range of experience levels:
8% have been with the company for less than 1 year23% for 1–2 years23% for 3–4 years38% for 5–7 years8% for 8–10 yearsEx-employees positions
In Company
In New Company
Contact top employees from
4:59 NewCo, a 5AM Ventures Company
Andrew Denninger
Senior Scientist
Hanmo Zhang
Medicinal Chemist
Geoff Otto
Product Development
Daniel Tate
VP, Intellectual Property
Jessica Alfano
Head of Legal
Nicole Carta
Vice President Human Resources
Stephanie Martin
Associate Scientist
Margareth Cheng
Associate Scientist
Corrie Painter
VP External Research & Partnerships
William Shen
Chief Business Officer
Deborah Palestrant
Executive Chair
Anna Schinzel
Director, Discovery Pharmacology at 4:59 NewCo
Lori Rudolph
Chief Development Officer (CDO)
Dave Wagner
Director, DMPK
Charles Allen
Controller
Jessica Friedman
Vice President, Discovery Pharmacology
Katy Ovington
Senior Scientist
Bayard Huck
Chief Discovery Officer
Shivam Verma
Lead Machine Learning Scientist
Noah Wagner
Scientist, Chemistry
